RareSearch logo

BioLamina

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Celia Quitzon profile

Celia Quitzon

πŸ‡©πŸ‡ͺ Germany

8.7

    Reviewed:

  • - Patient Recruitment
  • - 8 weeks March - April 2023
  • - Clinical Research Organization

Highly effective patient recruitment strategies, project completed on time.

The patient recruitment strategies were highly effective, and the project was completed within the agreed timeframe. The team was very professional, and their expertise in patient engagement was evident throughout.

Sarah Torphy profile

Sarah Torphy

πŸ‡¨πŸ‡¦ Canada

9.2

    Reviewed:

  • - Data Analysis
  • - 4 weeks January 2023
  • - Pharmaceutical Company

Thorough data analysis, timely delivery, excellent communication throughout.

The team provided exceptional data analysis services, and the project was completed well within the timeline. Communication was clear and consistent, which made the whole process smooth. Highly recommended for anyone needing reliable clinical data management.

Eula Borer profile

Eula Borer

πŸ‡―πŸ‡΅ Japan

5.6

    Reviewed:

  • - Clinical Data Management
  • - 8 weeks December 2023 - February 2024
  • - Biotech Company

Delayed delivery and lack of communication during the project.

The data management services were delayed, and communication from the team was lacking. It was difficult to get updates, and when the deliverables arrived, they were not as polished as expected. The delays impacted our project timeline significantly.

David Rodriguez profile

David Rodriguez

πŸ‡·πŸ‡Ί Russia

5.8

    Reviewed:

  • - Biostatistical Design
  • - 6 weeks February - March 2024
  • - Research Institution

Biostatistical analysis lacked depth, missed key insights.

The biostatistical analysis provided was not as thorough as we had hoped. Some key insights were missed, and we had to engage another provider to get the level of detail we needed. The team seemed overworked and under-resourced.

Irvin Daniel profile

Irvin Daniel

πŸ‡ΈπŸ‡¦ Saudi Arabia

9.1

    Reviewed:

  • - HTA Submission
  • - 8 weeks February - March 2024
  • - Biotech Company

Comprehensive and well-executed HTA submission.

The HTA submission was comprehensive and well-executed. The team managed the complexities of the submission process expertly, ensuring that all necessary data was included and well-presented.

Clifford D'Amore-Johnston profile

Clifford D'Amore-Johnston

πŸ‡ΉπŸ‡· Turkey

6

    Reviewed:

  • - Health Technology Assessment
  • - 8 weeks July - September 2024
  • - Pharmaceutical Company

Health technology assessment was superficial, lacked thorough analysis.

The health technology assessment (HTA) was superficial and did not provide the level of thorough analysis we needed. Some important factors were overlooked, and we had to request additional work to cover these gaps. The overall experience was disappointing.

Susan Purdy profile

Susan Purdy

πŸ‡¨πŸ‡­ Switzerland

8.6

    Reviewed:

  • - Patient Engagement
  • - 8 weeks August - September 2023
  • - Clinical Research Organization

Impressive patient engagement strategies, significant improvement in recruitment rates.

The patient engagement strategies implemented were impressive and led to a significant improvement in our recruitment rates. The team's experience in patient-centered approaches was evident and made a real difference.